Monsanto Company (MON) announced today that it will provide a royalty-free research license to the academic community and other non-profit research institutions to a newly issued US Patent related to the Agrobacterium transformation method.
Through these methods and continued advancements in breeding, plant researchers have been able to develop crops with improved nutritional profiles, plants that can better mitigate the effects of drought, as well as other agronomic improvements such as herbicide-tolerance and insect-protection.
In 2011, nearly 17 million farmers grew biotech crops on approximately 400 million acres in 29 countries around the world. Monsanto maintains biotech crops have supported the alleviation of poverty by improving the productivity or income of millions of small-holder farmers.
"We hope that access to one of the leading agricultural biotechnologies can further both the enablement and development of key agriculture solutions for farmers and consumers alike," said Robb Fraley, Chief Technology Officer for Monsanto Company and also one of the leading scientists behind this breakthrough discovery.
Fraley noted that the continued, successful development of crop products and novel agriculture technologies by both the public and private sector represents an important part of supporting the growing food, feed and fuel demands of our planet and its finite resources.
Monsanto (MON) trending upward over the past six months, currently at $89.53 - $0.74 lower from today's open at $90.27.